Comorbid substance use disorders may complicate treatment for both the hepatologist and psychiatrist. Comprehensive assessment of psychiatric illness and psychopharmacological management may be critical.
Robert D. Canning, PhD
Advertisement
Articles by Robert D. Canning, PhD
Advertisement
Latest Updated Articles
- Depression as Co-Pilot: Clinical Implications of Hepatitis C and Interferon/Ribavirin Treatment
Published: April 1st 2005 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Evidence-Based Psychotherapy and Psychopharmacology for Mood Disorders: A Conversation With Holly A. Swartz, MD
2
Can the Initial Antipsychotic Influence Years of Weight Gain?
3
New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms
4
Reflections on Developments in Correctional Psychiatry, with Tony Tamburello, MD
5
